ストックスクリーナーアプリを入手
0.6256
2.87%
-0.0185
アフターアワーズ：
.63
0.0044
+0.70%
前日終値:
$0.6441
開ける：
$0.6369
24時間の取引高:
854.58K
Relative Volume:
0.47
時価総額：
$16.10M
収益：
-
当期純損益:
$-23.36M
株価収益率:
-0.8491
EPS:
-0.7368
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-17.79%
1か月 パフォーマンス:
-48.72%
6か月 パフォーマンス:
-60.90%
1年 パフォーマンス:
-92.77%
1日の値動き範囲:
$0.58
$0.6483
1週間の範囲:
$0.58
$0.78
52週間の値動き範囲:
$0.58
$16.80
Calidi Biotherapeutics Inc Stock (CLDI) Company Profile
名前
Calidi Biotherapeutics Inc
セクター
電話
(858) 794-9600
住所
4475 Executive Drive, Suite 200, San Diego
CLDI を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CLDI
Calidi Biotherapeutics Inc
|
0.6256 | 16.10M | 0 | -23.36M | 0 | -0.7368 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.40 | 113.67B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
683.08 | 74.97B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
665.68 | 40.50B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
277.16 | 35.95B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
120.88 | 29.63B | 3.30B | -501.07M | 1.03B | -2.1146 |
Calidi Biotherapeutics Inc Stock (CLDI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-11-22 | 開始されました | H.C. Wainwright | Buy |
| 2023-10-09 | 開始されました | Robert W. Baird | Outperform |
Calidi Biotherapeutics Inc (CLDI) 最新ニュース
CLDI Stock Plummets to 52-Week Low at $0.6 Amid Market Turbulence - Investing.com
Calidi Biotherapeutics Bolsters Cash Balance and Terminates Standby Equity Purchase AgreementSAN DIEGO, January 28, 2025 – Calidi Biotherapeutics Inc. (NYSE American: CLDI) recently disclosed the ending cash balance amounting to approximately $ - Defense World
Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on February 5 - The Manila Times
Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on February 5 - GlobeNewswire
Inside Calidi's Game-Changing Cancer Treatment Pipeline: Top Execs Reveal Next-Gen Therapies - StockTitan
CLDICalidi Biotherapeutics, Inc. Latest Stock News & Market Updates - StockTitan
Calidi Biotherapeutics Ends SEPA After Successful Fundraising - TipRanks
Calidi Biotherapeutics Announces Bolstered Cash Balance and Termination of its Standby Equity Purchase Agreement - GlobeNewswire
Cancer Biotech Raises $18.8M War Chest to Fast-Track Revolutionary Brain Cancer Treatment - StockTitan
Why Calidi Biotherapeutics Inc (AMEX: CLDI) Is A Great Stock Pick For Momentum Investors - Stocks Register
CLDI stock touches 52-week low at $0.73 amid market challenges - MSN
The Business Case For Buying Calidi Biotherapeutics Inc (AMEX: CLDI) Stock Now - Stocks Register
Calidi Biotherapeutics Announces Presentation of New Data - GlobeNewswire
Calidi Biotherapeutics to Present Breakthrough Cancer Treatment Platform at AACR 2025 Meeting - StockTitan
Calidi Biotherapeutics announces reverse stock split adjustment - Investing.com
Calidi Biotherapeutics Inc (CLDI-A) QuotePress Release - The Globe and Mail
Calidi Biotherapeutics Announces $4.25 Million Public Stock Offering - Defense World
Calidi Biotherapeutics Refiles Consolidated Financial Statements After Reverse Stock Split - Defense World
Calidi Biotherapeutics Announces Closing of $4.25 Million Public Offering of Common Stock - The Bakersfield Californian
Calidi Biotherapeutics Raises $4.25M Through Public Offering of Common Stock at $0.85 Per Share - StockTitan
Why Calidi Biotherapeutics (CLDI) Stock Is Down 30% - Benzinga
Calidi Biotherapeutics slumps 29%, prices $4.25M stock offering - MSN
Calidi Biotherapeutics Announces Public Stock Offering Deal - TipRanks
Calidi Biotherapeutics Announces Pricing of $4.25 Million Public Offering of Common Stock - The Bakersfield Californian
Calidi Biotherapeutics Raises $4.25M Through Public Offering to Advance Cancer Immunotherapy Platform - StockTitan
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Calidi Biotherapeutics (NYSE:CLDI) Stock Price Down 8.2% – Should You Sell? - Defense World
Calidi Biotherapeutics Announces Proposed Public Offering - The Manila Times
Calidi Biotherapeutics Announces Common Stock Public Offering to Advance Immunotherapy Pipeline - StockTitan
Reviewing Calidi Biotherapeutics (NYSE:CLDI) & iTeos Therapeutics (NASDAQ:ITOS) - Defense World
Comparing Calidi Biotherapeutics (NYSE:CLDI) & Immatics (NASDAQ:IMTX) - Defense World
Calidi Biotherapeutics CEO Allan Camaisa sells $16,200 in stock - Investing.com India
Calidi Biotherapeutics prices $7.5M secondary offering - MSN
Calidi Biotherapeutics (NYSE American: CLDI) Data Demonstrates Potential of Innovative Solutions to Revolutionize Cancer Care - Barchart
UMACUnusual Machines, Inc. Latest Stock News & Market Updates - StockTitan
Calidi Biotherapeutics (NYSE American: CLDI) Shares Data Supporting Proprietary Systemic Antitumor Platform - Barchart
Calidi Biotherapeutics announces pricing of $7.5M public offering of common stock - MSN
Calidi Biotherapeutics (NYSE American: CLDI) Raises $7.5 Million Through Public Stock Offering - Barchart
If You Don’t Buy Calidi Biotherapeutics Inc (AMEX: CLDI) Now, You’ll Kick Yourself Later - Stocks Register
Calidi Biotherapeutics Reveals Promising Virotherapy Data - TipRanks
Calidi Biotherapeutics Presents Data Supporting RTNova Systemic Technology to Target Metastatic Lung Cancer - EIN News
Calidi presents data on RTNova systemic technology in metastatic lung cancer - TipRanks
Calidi Bio's RTNova Shows Promise in Metastatic Lung Cancer Treatment Breakthrough | CLDI Stock News - StockTitan
Calidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock - The Manila Times
Calidi Biotherapeutics Raises $7.5M Through Public Offering of 4.4M Shares | CLDI Stock News - StockTitan
Pre-market Movers: GANX, TFFP, AKYA, CLDI... - RTTNews
SEC Form 424B5 filed by Calidi Biotherapeutics Inc. - Quantisnow
Calidi prices 4.4M shares at $1.69 in public offering - TipRanks
Calidi Biotherapeutics Inc (CLDI) 財務データ
収益
当期純利益
現金流量
EPS
5.49%
0.79%
大文字化:
|
ボリューム (24 時間):